Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 984

1.
2.

The financing and organization of medical care for patients with end-stage renal disease in Sweden.

Wikström B, Fored M, Eichleay MA, Jacobson SH.

Int J Health Care Finance Econ. 2007 Dec;7(4):269-81.

PMID:
17657602
3.

The organization and financing of end-stage renal disease in Spain.

Luño J.

Int J Health Care Finance Econ. 2007 Dec;7(4):253-67.

PMID:
17602295
4.

The organization and financing of dialysis and kidney transplantation services in New Zealand.

Ashton T, Marshall MR.

Int J Health Care Finance Econ. 2007 Dec;7(4):233-52.

PMID:
17638073
5.

International Study of Health Care Organization and Financing of renal services in England and Wales.

Nicholson T, Roderick P.

Int J Health Care Finance Econ. 2007 Dec;7(4):283-99.

PMID:
17653861
6.

The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.

Lacson E Jr, Hakim RM.

Am J Kidney Dis. 2011 Apr;57(4):547-9. doi: 10.1053/j.ajkd.2011.01.008. Epub 2011 Feb 17. No abstract available.

PMID:
21333423
7.

Financing of end-stage renal disease care: past, present, and future.

Farley DO.

Adv Ren Replace Ther. 1994 Apr;1(1):24-31. Review.

PMID:
7641085
8.

The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.

Bhat P, Bhat JG.

Am J Kidney Dis. 2011 Apr;57(4):556-8. doi: 10.1053/j.ajkd.2011.01.012. No abstract available.

PMID:
21316132
9.

The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.

Nissenson AR, Mayne TJ, Krishnan M.

Am J Kidney Dis. 2011 Apr;57(4):550-2. doi: 10.1053/j.ajkd.2011.01.009. Epub 2011 Feb 17. No abstract available.

PMID:
21333425
10.

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Dor A, Pauly MV, Eichleay MA, Held PJ.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):73-111. Review.

PMID:
17653860
11.

The 2011 ESRD prospective payment system: welcome to the bundle.

Weiner DE.

Am J Kidney Dis. 2011 Apr;57(4):539-41. doi: 10.1053/j.ajkd.2011.01.007. Epub 2011 Feb 18. No abstract available.

PMID:
21333431
12.

The 2011 ESRD prospective payment system: an uncontrolled experiment.

Winkelmayer WC, Chertow GM.

Am J Kidney Dis. 2011 Apr;57(4):542-6. doi: 10.1053/j.ajkd.2011.01.013. Epub 2011 Feb 17. No abstract available.

PMID:
21333428
13.

The 2011 ESRD prospective payment system and the survival of an endangered species: the perspective of a not-for-profit medium-sized dialysis organization.

Johnson DS, Meyer KB, Johnson HK.

Am J Kidney Dis. 2011 Apr;57(4):553-5. doi: 10.1053/j.ajkd.2011.01.010. Epub 2011 Feb 18. No abstract available.

PMID:
21333427
14.

The direction of end-stage renal disease reimbursement in the United States.

Lockridge RS Jr.

Semin Dial. 2004 Mar-Apr;17(2):125-30. Review.

PMID:
15043614
15.

Health care policies/economics of the geriatric renal population.

Eggers PW.

Am J Kidney Dis. 1990 Oct;16(4):384-91.

PMID:
2121023
16.

Medicare program; end-stage renal disease prospective payment system. Final rule.

Centers for Medicare & Medicaid Services (CMS), HHS.

Fed Regist. 2010 Aug 12;75(155):49029-214.

17.

Patient selection in the Medicare End-Stage Renal Disease Program.

de Lissovoy G.

Med Care. 1988 Oct;26(10):959-70.

PMID:
3139942
18.

A quarter century of medicare expenditures for ESRD.

Eggers PW.

Semin Nephrol. 2000 Nov;20(6):516-22.

PMID:
11111852
19.

National health insurance: lessons from the United States experiment.

Derrick FW, Scott CE.

Health Care Manage Rev. 1995 Summer;20(3):55-63.

PMID:
7591752
20.

Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.

De Vecchi AF, Dratwa M, Wiedemann ME.

Nephrol Dial Transplant. 1999;14 Suppl 6:31-41. Review.

PMID:
10528710

Supplemental Content

Support Center